PUBBLICAZIONE/PUBLICATION

Permanent URI for this communityhttps://gendermore.unimore.it/handle/123456789/1575

Browse

Settings

Discipline: search.filters.discipline.CardiologyViewpoints: search.filters.viewpoints.Peer Review System

Search Results

Now showing 1 - 1 of 1
  • Item type:Publication,
    Ending Gender Inequality in Cardiovascular Clinical Trial Leadership: JACC Review Topic of the Week Open PDF 
    (2021)
    Van Spall, Harriette G. C.
    ;
    Lala, Anuradha
    ;
    Deering, Thomas F.
    ;
    Casadei, Barbara
    ;
    Zannad, Faiez
    Women are under-represented as leaders of cardiovascular randomized controlled trials, representing 1 in 10 lead authors of cardiovascular trials published in high-impact journals. Although the proportion of cardiovascular specialists who are women has increased in recent years, the proportion of cardiovascular clinical trialists who are women has not. This gap, underpinned by systemic sexism, has not been adequately addressed. The benefits of diverse randomized controlled trial leadership extend to patients and professionals. In this position statement, we present strategies adopted by some organizations to end gender inequality in research leadership. We offer an actionable roadmap for early-career researchers, scientists, academic institutions, professional societies, trial sponsors, and journals to follow, with the goal of harnessing the strength of women and under-represented groups as research leaders and facilitating a just culture in the cardiovascular clinical trial enterprise.